Century Therapeutics, Inc.
IPSC
$2.44
$0.146.09%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.17M | -34.43M | -32.54M | 76.56M | -36.07M |
| Total Depreciation and Amortization | 3.55M | 3.13M | 3.20M | 3.22M | 3.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.61M | 6.51M | 2.45M | 1.81M | 6.70M |
| Change in Net Operating Assets | 3.16M | -795.00K | -704.00K | -116.21M | 1.83M |
| Cash from Operations | -16.08M | -25.58M | -27.59M | -34.62M | -24.22M |
| Capital Expenditure | 139.00K | -195.00K | -317.00K | -475.00K | -154.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -21.00K |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.22M | 24.87M | 32.86M | 28.41M | 30.78M |
| Cash from Investing | 22.36M | 24.67M | 32.54M | 27.93M | 30.61M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 53.00K | 0.00 | 0.00 | 120.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -602.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 53.00K | 0.00 | 0.00 | 120.00K | -602.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.34M | -913.00K | 4.95M | -6.57M | 5.78M |